Some studies, however, suggest a pro-invasive effect of the weak and modestly selective ERβ ligand, di-aryl propionitrile, in triple negative SUM149 inflammatory breast cancer cells, an effect that MEK inhibition reversed (136). The gene discussed is ESR2; the disease is breast carcinoma.